1. Academic Validation
  2. Aminothiazolomorphinans with mixed κ and μ opioid activity

Aminothiazolomorphinans with mixed κ and μ opioid activity

  • J Med Chem. 2011 Mar 24;54(6):1903-13. doi: 10.1021/jm101542c.
Tangzhi Zhang 1 Zhaohua Yan Anna Sromek Brian I Knapp Thomas Scrimale Jean M Bidlack John L Neumeyer
Affiliations

Affiliation

  • 1 Alcohol & Drug Abuse Research Center, McLean Hospital, Harvard Medical School, 115 Mill Street, Belmont, Massachusetts 02478, United States.
Abstract

A series of N-substituted and N'-substituted aminothiazole-derived morphinans (5) were synthesized for expanding the structure-activity relationships of aminothiazolo-morphinans. Although their affinities were somewhat lower than their prototype aminothiazolo-N-cyclopropylmorphinan (3), 3-aminothiazole derivatives of cyclorphan (1) containing a primary amino group displayed high affinity and selectivity at the κ and μ opioid receptors. [(35)S]GTPγS binding assays showed that the aminothiazolomorphinans were κ agonists with mixed agonist and antagonist activity at the μ Opioid Receptor. These novel N'-monosubstituted aminothiazole-derived morphinans may be valuable for the development of drug abuse medications.

Figures